Failure to Satisfy Listing Rule Form 8 K

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On September 24, 2024, Inspire Veterinary Partners, Inc. (the "Company") received a staff determination letter from the Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market ("Nasdaq") notifying the Company that, based on its review of the Company's securities, the Staff determined that the Company failed to comply with Nasdaq's shareholder approval requirements set forth in Listing Rule 5635(d). The Staff stated that the Company's "best efforts" public offering, which closed on July 15, 2024, did not qualify as a public offering for the purposes of Nasdaq's shareholder approval rules.

As such, Listing Rule 5635(d ),which requires prior shareholder approval for transactions other than public offerings involving the issuance of 20% or more of the pre-transaction shares outstanding at less than the Minimum Price was not met. Accordingly, this matter serves as an additional basis for delisting the Company's securities from Nasdaq.

The Company will present its views with respect to this additional deficiency to the Nasdaq Hearings Panel (the "Panel") in writing no later than October 1, 2024. The Company's securities will not be suspended or delisted while the Panel makes its determination regarding the Company's continued listing on Nasdaq.